Skip to content

The Effect of the Use of Computer Game- My Diabetic Friend in Children With Type 1 Diabetes

Randomized Controlled Trial to Evaluate the Effect of 3 Months Use With Interactive Computer Game- My Diabetic Friend-Comparing to Conventional Diabetes Education on Metabolic Control, Quality of Life and Diabetes Knowledge in Children With Type 1 Diabetes.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01600664
Enrollment
30
Registered
2012-05-17
Start date
2012-06-30
Completion date
2013-08-31
Last updated
2014-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes, My Diabetic friend, interactive computer game

Brief summary

A randomized controlled study to evaluate the effect of 3 months use with interactive computer game- My Diabetic Friend- comparing to conventional diabetes education on metabolic control, quality of life and diabetes knowledge.Patients will be randomized into two groups- one group will be supplied with interactive computer game, My Diabetic friend, installed on a computer designed for children's educational needs for a period of three months and the other group will be supplied with the same computer without the interactive computer game for three months. Metabolic control, quality of life and diabetes knowledge will be evaluated before and after the use of the computer. The trial is consisting of two main periods: 3 months of the main study period and an optional extension period consisting of the following 3 months : The study will include two main periods; 1. Period 1 which will last 3 months, in a randomized controlled manner, this period will serve as the main study period to assess the primary and secondary endpoints of the study. 2. Period 2: this extension period will not be an integral part of the study, and only patients who are willing will take part at this period, will continue to participate at the optional extension period. During the extension period, patients in the intervention group will be offered to continue the use of the Computer game -My diabetic friend) for the following 3 months, and patients who participated at the control group during period 1, will be offered to start to use the Computer Game - My Diabetic Friend for the following 3 months.

Interventions

BEHAVIORALInteractive computer game

Participants will use the interactive computer game installed on a convertible PC

BEHAVIORALConvertible PC

Participants will be using the convertible PC without the interactive computer game

Sponsors

Intel Corporation
CollaboratorINDUSTRY
Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

1. Type 1 diabetes diagnosed at least one year prior to study entry. 2. Age:7-11 years old. 3. Treatment either with CSII or MDI. 4. HbA1c\>8.0% 5. Signing an informed consent form.

Exclusion criteria

1. Any significant disease or conditions, including psychiatric disorders that in the opinion of the investigator are likely to affect subject compliance or subject's ability to complete the study. 2. Inability to understand/ complete the questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeAfter 12 weeks (end of study)Quality of life questionnaires will be completed

Secondary

MeasureTime frameDescription
Diabetes knowledgeAfter 12 weeksDiabetes knowledge questionnaires will be completed
Patient's gaming durationAfter 12 weeksThe frequency and the duration of use of the interactive computer game by each participant will be monitored by the study team
Compliance to diabetes treatmentAfter 12 weeksPatient's parents will undergo clinical interview about patient's diabetes adherence
Average glucose levelsAfter 12 weeks (end of study)
Metabolic controlAfter 12 weeks (end of study)HbA1c will be measured
Measurements within normal rangeAfter 12 weeks (end of study)
Hypoglycemia eventsAfter 12 weeks (end of study)
Hyperglycemia eventsAfter 12 weeks (end of study)
Average number of blood glucose measurementsAfter 12 weeks (end of study)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026